Bionano Genomics, Inc. Warrant
BNGOW
BNGOW was delisted on the 17th of August, 2023.
1 hedge funds and large institutions have $0 invested in Bionano Genomics, Inc. Warrant in 2021 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
50% less funds holding
Funds holding: 2 → 1 (-1)
100% less capital invested
Capital invested by funds: $277K → $0 (-$277K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ICM
Ionic Capital Management
New York
|
-$276K |
BNGOW Hedge Fund Activity: Q3 2021 in Review
1 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in Bionano Genomics, Inc. Warrant (BNGOW) for Q3 2021, worth a combined $0 — down 100% from $277K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of BNGOW and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Ionic Capital Management, exiting entirely with an estimated $276K sold.
- 1 institutional investor held Bionano Genomics, Inc. Warrant (BNGOW) as of Q3 2021, down from 2 in Q2 2021.
- Funds reported $0 of Bionano Genomics, Inc. Warrant stock for Q3 2021, down 100% quarter-over-quarter.
- 0 funds opened new Bionano Genomics, Inc. Warrant positions in Q3 2021 and 1 closed out, a net change of -1 holder.
- The largest Bionano Genomics, Inc. Warrant seller in Q3 2021 was Ionic Capital Management, an estimated $276K sold.
Based on aggregated 13F filings for Q3 2021.